Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BRN01 is a novel therapeutic approach that has been explored in two distinct contexts. Most notably, it refers to a homeopathic formulation investigated for the management of hot flashes in women with breast cancer. In this context, BRN01 was evaluated in clinical trials as an intervention to reduce hot flash scores after four weeks of treatment compared to placebo[3]. Separately, there are references to "BRN01" as a potential therapy for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease; however, details on its composition or mechanism in these indications remain unclear[1]. The available evidence most concretely supports its use as a homeopathic product for vasomotor symptoms associated with breast cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BRN01.